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Abstract
Background and aims: Approximately 20% of patients 
having total knee arthroplasty (TKA) will experience 
chronic postoperative pain. Recently, preoperative pain 
facilitation has been associated with chronic pain after 
TKA, and gabapentin has been shown to decrease pain 
facilitation. The current study is a secondary follow-up 
of a primary RCT investigating the effect of gabapentin 
on acute postoperative pain after TKA and exploring the 
effect of pre- and perioperative administration of gabap-
entin on chronic postoperative pain and psychological 
state 3–4 years after TKA.
Methods: Patients scheduled for TKA were randomized to 
either gabapentin 1,300 mg/day, gabapentin 900 mg/day, 
or placebo daily from 2-h before and 6 days after operation. 
Pre- and 3–4 years postoperatively pain scores related to 
pain while walking, at rest, when flexing the hip or the 
knee were collected. At the same time, the pain catastro-
phizing scale (PCS) and hospital anxiety and depression 
scale subscales for anxiety (HADS-A) and depression 
(HADS-D) were collected.
Results: Lower postoperative pain while walking, flexing 
the hip, and at rest were found compared with preopera-
tive scores (p < 0.03), but these were not associated with 
gabapentin treatment (p > 0.19). Significantly lower post-
operative PCS and HADS-A scores were seen compared 
with preoperative scores (p < 0.001), but these were not 
associated with gabapentin treatment (p > 0.55).
Conclusions: The current study found that pre- and perio-
perative administrations of gabapentin do not influence 
the pain or psychological state 3–4 years after TKA.
Implications: The current study does not support that 
short-term pre- and perioperative use of gabapentin can 
reduce the development of chronic postoperative pain 
after TKA.
Keywords: total knee arthroplasty; gabapentin; chronic 
postoperative pain; psychological assessments.
1   Introduction
Total knee arthroplasty (TKA) surgery is considered an 
effective intervention to improve function and reduce 
pain in the end-stage of knee osteoarthritis (KOA). In the 
US alone, the number of TKAs have increased from 31.2 
per 100,000 persons in the period 1971–1976 to 220.9 in 
the period 2005–2008 [1]. By 2030, the incidence of TKA 
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is expected to be increased by approximately 700% in the 
US [2], and as the incidence of chronic postoperative pain 
following TKA remains at approximately 20% [3], one of 
the main challenges is to reduce postoperative pain.
Several pre- and perioperative risk factors for chronic 
postoperative TKA have been suggested [4, 5] where the 
major risk factors are preoperative, heightened, psycho-
logical factors related to pain (e.g. pain catastrophizing, 
anxiety, or depression) [6], high pre- and perioperative 
pain intensities [7–9] and more recently preoperative pain 
sensitivity [8, 10–12]. Gabapentinoids have an anxiolytic 
effect [13–15] and reduce neuronal hyperexcitability [16], 
and it has been suggested that preoperative and periop-
erative administration of gabapentinoids may reduce the 
incidence of chronic postoperative pain. In this context, 
Buvanendran et  al. [17] administered pregabalin on the 
day of surgery and 14  days following TKA and found a 
reduction in neuropathic pain 3 and 6 months after TKA 
compared with placebo.
Several older reviews and meta-analyses [18–22], con-
cludes that gabapentinoids reduce pain in the first post-
operative days. However, recent meta-analyses have shed 
critical light on most of the perioperative gabapentinoid 
literature and concluded that the quality of evidence is 
low, firm evidence for the use in postoperative pain man-
agement is lacking, the clinically relevant beneficial effect 
seems absent, and there may be a risk of harm [23, 24].
The mechanism-of-action for gabapentinoids is not 
completely understood, but gabapentinoids bind to the 
α2-δ subunit of voltage-sensitive calcium channels in the 
presynaptic dorsal horn neuron [25, 26] and inhibit the 
release of neurotransmitters, decreasing the pain facilita-
tion of the dorsal horn neurons [27], and thereby reducing 
the pain facilitation [28]. In addition, studies support the 
effects on peripheral [29], primary afferent neurons [30], 
and a recent study found that gabapentin acts on both 
spinal and supraspinal mechanisms [31]. A measure of 
pain facilitation is temporal summation of pain (TSP), and 
gabapentin has been shown to decrease TSP in healthy sub-
jects [16]. Preoperatively, facilitated TSP has been linked to 
the development of chronic postoperative pain following 
total hip arthroplasty surgery [10], TKA [8, 11, 12], and acute 
postoperative pain following thoracotomy [32], indicating 
that preoperative administration of gabapentinoids could 
potentially reduce the risk of developing chronic postoper-
ative pain. Since, preoperative administration of pregabalin 
has been found to diminish neuropathic chronic postop-
erative pain following TKA [17], the current study hypoth-
esized that different doses of gabapentin would reduce the 
prevalence of chronic postoperative pain following TKA 
and aimed to explore the effect of pre- and perioperatively 
administered gabapentin on the development of chronic 
postoperative pain in patients undergoing TKA. The current 
study is a secondary follow-up of a previously published 
primary RCT investigating the effect of gabapentin on acute 
postoperative pain after TKA [33].
2   Methods
2.1   Design and patients
This study is a secondary follow-up of a previously pub-
lished primary RCT investigating the effect of gabapentin 
on acute postoperative pain after TKA [33] and patients who 
were reachable were included in the analysis. The primary 
study was approved by the Danish Medicines Agency, the 
regional Ethics Committee, and the Danish Data Protec-
tion Agency and was registered at EudraCT (2011-003105-
22) and www.clinicaltrials.gov (NCT01507363, January 6, 
2012). The primary RCT was conducted in accordance with 
good clinical practice principles and was monitored by 
the Danish good clinical practice monitoring units. Oral 
and written informed consents were obtained from all 
patients [33].
Patients scheduled to undergo elective, unilateral 
primary TKA were assessed for eligibility (by surgeons/
project nurses) and recruited from participating centers 
at a prescheduled (study independent) hospital visit for 
clinical examination preceding admission for surgery at 
the Departments of Orthopedic Surgery, Copenhagen Uni-
versity Hospital, Hvidovre, Denmark; Aalborg University 
Hospital, Farsø, Denmark; and South of Denmark Uni-
versity Hospital, Grindsted, Denmark. Exclusion criteria 
were age above 85 and below 50 years, non-ethnic Danes, 
preoperative use of gabapentinoids, antiepileptics, anxi-
olytics, antidepressants, systemic glucocorticoids, or 
opioids of any kind (within 4  weeks), history of bipolar 
affective disorder, alcohol or drug abuse, history of malig-
nant disease, body mass index (BMI) >40 kg/m2, diseases 
affecting central or peripheral nerve function, history of 
dementia, or other cognitive dysfunction, history of renal 
insufficiency, allergies to gabapentin, and fertile women 
(menstruation within 2 years).
2.2   Randomization, blinding, and study 
drug intervention
Detailed information regarding randomization, blinding, 
and study drug intervention has previously been described 
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[33], but in brief, the randomization and blinding pro-
cedures together with the study drug preparations were 
handled by a state-registered and certificated pharmacy, 
The Capital Regional Pharmacy, not otherwise involved 
in the trial. A computer produced 1:1:1 random allocation 
sequence (A, B and C) was generated in blocks of 12 (25 
blocks) without the use of stratification variables, using 
the free internet service “www. Randomization.com”. The 
study drugs, oral gabapentin 300  mg and 400  mg, and 
placebo, were prepared by the pharmacy as small cap-
sules, identical in appearance. The capsules were admin-
istered twice a day for 7 days, starting 2 h preoperatively, 
again at 10 PM on the day of surgery, and thereafter at 
8 AM and 10 PM on postoperative days 1–6 [33].
Group A: Gabapentin “high dose” group received gabap-
entin 1,300  mg/day: 900  mg preoperatively and 400  mg 
at 10:00 PM on the day of surgery, thereafter 400  mg at 
8:00 AM and 900 mg at 10:00 PM.
Group B: Gabapentin “low dose” group received gabap-
entin 900 mg/day: 600 mg preoperatively and 300 mg at 
10:00 PM, thereafter 300  mg at 8:00 AM and 600  mg at 
10:00 PM.
Group C: Placebo group received placebo throughout the 
study period.
The dosage was determined based on the pharmacody-
namics and kinetic characteristics of gabapentin [25] 
and on the few existing (smaller sized) dose-finding 
studies showing that higher perioperative dose regimens 
seem more effective than lower dose regimens, 1,200 or 
900 mg reported in one study [34] and ≥600 mg reported 
in another [35].
2.3   Follow-up assessments
The primary study with data on pre- and six first post-
operative days has previously been published [33]. The 
current secondary, exploratory work focuses on follow-
up 3–4 years after TKA surgery. Prior to surgery, patients 
filled out questionnaires regarding pain intensities and 
psychological distress. At the same time, patients were 
contacted 3–4 years after surgery by phone, and the same 
questionnaires were completed during a telephone inter-
view. Patients who did not respond to several attempts 
of telephone calls were contacted by letter. Patients who 
did not respond to the written invitation were classified as 
non-responders. Furthermore, patients who did not wish 
to participate in the telephone interview or were otherwise 
uncontactable were classified as non-responders.
2.4   Pain assessments
The pain intensity scores during walking, at rest (supine), 
upon 45 ° hip flexion with straight leg, and upon passive 
60 ° knee flexion were collected. A 100-mm verbal numeric 
analog scale (NRS) was used (0 = no pain and 100 = worst 
pain imaginable).
2.5   Psychological assessments
Anxiety and depression symptoms were assessed using the 
hospital anxiety and depression scale (HADS) [36], which 
applies a subscale for anxiety (HADS-A) and a subscale 
for depression (HADS-D). The HADS ranges from 0 to 21; 
0 to 7 indicate no symptoms of anxiety/depression, 8 to 10 
indicate possible symptoms of anxiety/depression, and 11 
to 21 indicate severe symptoms of anxiety/depression [36]. 
In addition, pain catastrophizing was assessed using the 
pain catastrophizing scale (PCS) [37]. A PCS score below 
29 is considered a low pain catastrophizer whereas a score 
above 30 is considered a high pain catastrophizer [37].
2.6   Statistics
The data are presented as means and standard deviations 
(SD) unless otherwise stated. The revision rate since TKA 
surgery was examined between the three groups using a χ2-
test. Repeated measures analysis of variance (rm-ANOVA) 
was used to assess the differences in pre- and postopera-
tive pain, and psychological scores and adjustment for 
treatment groups were applied to assess if gabapentin 
influenced the outcome. The Bonferroni post hoc test was 
used in case of significant factors. Chi-squared (χ2)-tests 
investigated the differences in the number of patients 
reporting more than 30 mm at the NRS in the three groups.
Three prediction models assessing associations 
between pre- and post-operative factors were constructed. 
Initially, Pearson correlation analysis between preopera-
tive PCS, preoperative HADS (A and D), pre-operative pain 
scores and postoperative pain scores was conducted. Sec-
ondly, the correlation analysis was adjusted for the treat-
ment group to investigate if gabapentin influenced the 
predictive values. Finally, linear regressions were used to 
categorize independent parameters. p < 0.05 was consid-
ered significant.
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3   Results
Three-hundred patients were enrolled and randomized 
to administration of either high (group A) or low (group 
B) dose gabapentin or placebo (group C). Furthermore, 91 
patients were included for primary analysis in group A, 
92 patients in group B, and 91 patients in group C as pre-
viously described in the primary, original study by Lunn 
et al. [33]. For present follow-up study, the patients were 
re-contacted, and 68 patients in group A, 77 patients in 
group B, and 70 patients in group C responded to the invi-
tation. A non-responder analysis found that responders 
and non-responders had similar preoperative NRS scores 
(t-test: p > 0.21), BMI (t-test: p > 0.74), gender distribu-
tion (χ2: p > 0.62), age (t-test: p > 0.26), PCS levels (t-test: 
p > 0.69), HADS-A (t-test: p > 0.38), and HADS-D (t-test: 
p > 0.28).
Preoperative demographics for patients included 
in the follow-up are listed in Table  1. No significant 
differences were found between groups comparing 
age [ANOVA: F(2,212) < 0.47, p > 0.62], BMI [ANOVA: 
F(2,212) < 0.44, p > 0.63], time after surgery at follow-up 
[ANOVA: F(2,212) < 0.59, p > 0.55], or gender distribution 
(χ2: p > 0.59).
Table 1: Demographics for patients receiving high dose (1,300 mg/day, group A) or low dose (900 mg/day, group B) gabapentin or placebo 
(group C).
Demographics
  Group A 
(n = 68)
  Group B 
(n = 77)
  Group C 
(n = 70)
  Statistics
Age, years (mean ± SD)   66.9 ± 7.7  67.8 ± 8.5  66.7 ± 7.6  ANOVA: F(2,212) < 0.47, p > 0.62
BMI, kg/m2 (mean ± SD)   29.1 ± 4.1  29.6 ± 4.0  29.7 ± 4.5  ANOVA: F(2,212) < 0.44, p > 0.63
Gender distribution, females/males (percentage 
females of group)
  31/36 (46.3%)  37/40  28/42  χ2: p > 0.59
Time from surgery to follow-up, months (mean ± SD)   45.3 ± 5.1  45.2 ± 5.0  46.2 ± 7.3  ANOVA: F(2,212) < 0.59, p > 0.55
BMI = body mass index.
Figure 1: Comparison between preoperative (white bars) and postoperative (black bars) pain scores for pain while walking (A), pain at rest 
(B), pain while flexing the hip (C), and pain while flexing the knee (D). Knee osteoarthritis patients scheduled for total knee arthroplasty 
received pre- and perioperative high (group A) or low dose (group B) gabapentin or placebo (group C), and no differences in pain scores were 
seen between groups. *Indicates a significant difference (p < 0.05) comparing pre- and postoperative scores.
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3.1   Follow-up assessments – pain scores
At follow-up, three patients in group A (4.4% of group), 
four patients in group B (5.2% of group), and four patients 
in group C (5.7% of group) had received revision TKA 
surgery, which was not significantly different between 
the groups (χ2: p > 0.94). Significantly lower postopera-
tive pain scores were found for pain while walking [rm-
ANOVA: F(1,212) > 48.30, p < 0.0001], at rest [rm-ANOVA: 
F(1,212) > 4.93, p < 0.027], and while flexing the hip [rm-
ANOVA: F(1,212) > 15.13, p < 0.0001] compared with pre-
operative scores, Fig.  1. These results were independent 
of gabapentin treatment [rm-ANOVAs: F(2,212) < 1.68, 
p > 0.19], indicating that preoperative administration of 
gabapentin did not further improve the pain scores.
Similarly, the changes in the pain scores from preop-
erative to follow-up assessments showed no significant 
differences for any pain scores when comparing the three 
treatment groups [ANOVA: F(2,212) < 2.50, p > 0.08].
No differences were found in number of patients 
reporting more than 30  mm at the NRS for pain while 
walking (χ2: p > 0.19), at rest (χ2: p > 0.41), while flexing the 
hip (χ2: p > 0.27), and while flexing the knee (χ2: p > 0.20).
3.2   Follow-up assessment – psychological 
scores
Significantly lower PCS [rm-ANOVA: F(1,198) > 133.65, 
p < 0.001] and HADS-A [rm-ANOVA: F(1,199) > 33.20, 
p < 0.001] scores were found when comparing postop-
erative to preoperative scores, Fig. 2. These findings were 
independent of treatment [rm-ANOVA: F(2,198) < 0.60, 
p > 0.55], indicating that gabapentin did not influence the 
postoperative psychological follow-up.
Similarly, the changes from the preoperative to the 
follow-up assessments showed no significant differ-
ences for PCS [ANOVA: F(2,207) < 0.38, p > 0.67], HADS-A 
[ANOVA: F(2,204) < 0.37, p > 0.69], and HADS-D [ANOVA: 
F(2,204) < 0.37, p > 0.69] comparing the three treatment 
groups.
3.3   Associations between preoperative 
parameters and postoperative pain
The correlation analysis revealed weak, but significant 
correlations between preoperative HADS-D (r = 0.146, 
p = 0.034) and a trend towards significantly less pain 
during walking (r = 0.133, p = 0.051) and postoperative 
pain during walking. Further, preoperative pain at rest 
and postoperative pain at rest (r = 0.147, p = 0.032) were 
found to be associated. Finally, preoperative PCS (r = 0.159, 
p = 0.023) and a trend towards significant for preoperative 
HADS-D (r = 0.133, p = 0.055) were associated with postop-
erative pain during flexion of the hip (Table 2).
Adjusting these correlations for the treatment group 
yielded similar results indicating that treatment with 
gabapentin did not affect these associations and further 
indicating that treatment with gabapentin had no effect 
on the associations between preoperative and postopera-
tive factors (Table 3).
Linear regression models found preoperative HADS-D 
as an independent predictor for postoperative pain while 
walking (p = 0.013) and pain at rest (p = 0.013). In addition, 
preoperative HADS-A independently predicted postopera-
tive pain at rest (p = 0.015) and a trend for preoperative 
pain at rest as an independent preoperative predictor of 
Figure 2: Comparison between preoperative (white bars) and post-
operative (black bars) pain scores for (A) pain catastrophizing scale 
(PCS), (B) hospital anxiety and depression scale anxiety subscale 
(HADS-A), and (C) HADS depression subscale (HADS-D). Knee osteo-
arthritis patients scheduled for total knee arthroplasty received pre- 
and perioperative high (group A) or low dose (group B) gabapentin 
or placebo (group C), and no differences were seen comparing the 
groups for any of the psychological scores. *Indicates a significant 
difference (p < 0.05) comparing pre- and postoperative scores.
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postoperative pain at rest (p = 0.051). The treatment with 
gabapentin was not found to influence these models 
(p > 0.17), indicating that the gabapentin treatment did 
not improve the predictive value.
4   Discussion
Despite being a secondary follow-up of a primary RCT, 
this study is the first large trial to investigate the effect of 
pre- and perioperative administration of gabapentin on 
long-term pain after TKA. Gabapentin did not influence 
the chronic pain outcome or revision rate at 3–4  years 
follow-up. Further, preoperative HADS-D independently 
predicted postoperative pain while walking and at rest and 
preoperative HADS-A independently predicted pain at rest, 
but gabapentin was not associated with these predictions.
4.1   Effects of gabapentinoids on chronic 
postoperative pain
Yang et  al. [38] studied the effect of continuous infu-
sion of pregabalin on peripheral nerve injuries in rats 
Table 2: Pearson correlation coefficients (r) between pre- and post-operative factors.




Pain during walking, 
NRS-100 mm
  Pain at rest, 
NRS-100 mm
  Pain flex of the hip, 
NRS-100 mm




  Pain during walking, NRS-100 mm   r = 0.133
p = 0.051
     
  Pain at rest, NRS-100 mm     r = 0.147
p = 0.032
   
  Pain flex of the hip, NRS-100 mm       –  
  Pain flex of the knee, NRS-100 mm        –
  PCS   –   –   r = 0.159
p = 0.023
  –
  HADS-A   –   –   –   –
  HADS-D   r = 0.146
p = 0.034
  –   r = 0.133
p = 0.055
  –
PCS = pain catastrophizing scale; HADS-A = hospital anxiety and depression scale – anxiety subscale; HADS-D = hospital anxiety and depres-
sion scale – depression subscale.
Table 3: Correlations coefficients (r) between pre- and post-operative factors adjusted for gabapentin treatment.




Pain during walking, 
NRS-100 mm
  Pain at rest, 
NRS-100 mm
  Pain flex of the hip, 
NRS-100 mm




  Pain during walking, NRS-100 mm   r = 0.162
p = 0.022
     
  Pain at rest, NRS-100 mm     r = 0.153
p = 0.031
   
  Pain flex of the hip, NRS-100 mm       –  
  Pain flex of the knee, NRS-100 mm        –
  PCS   –   –   r = 0.135
p = 0.058
  –
  HADS-A   –   –   –   –
  HADS-D   r = 0.164
p = 0.020
  –   r = 0.156
p = 0.028
  –
PCS = pain catastrophizing scale; HADS-A = hospital anxiety and depression scale – anxiety subscale; HADS-D = hospital anxiety and depres-
sion scale – depression subscale.
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and while pregabalin did affect the responses to an 
experimental pain test, there was no preventive effect 
of pregabalin on postoperative neuropathic pain com-
pared with placebo. In the context of TKA, Buvanen-
dran et  al. [17] administered pregabalin 300  mg on the 
day of TKA surgery and 300 mg/daily in the following 10 
postoperative days and found this to reduce the risk of 
postoperative neuropathic pain at 3- and 6-months fol-
low-up compared with placebo. Several old reviews and 
meta-analyses have highlighted a pain-relieving effect 
of preoperative administration of gabapentin on pain 
in the first postoperative days [18–22]. In contrast, more 
recent reviews have highlighted that gabapentinoids 
might have minimal opioid sparring effect in the acute 
postoperative phase, but the severe adverse events are 
increased [24], and the evidence is based on low quality 
studies [23]. A recent review on the effect of preopera-
tive administration of gabapentin and pregabalin prior 
to breast cancer surgery found no associations between 
the administration of either drug on the development of 
chronic postoperative pain [39]. Conclusively, a recent 
review and meta-analysis [40] summarized the adminis-
tration of perioperative pregabalin across several surgi-
cal interventions and found no preventive effect on the 
development of pain 3, 6 and 12-months after surgery. 
The current study supports no additional effect by the 
administration of short time preoperative gabapentin 
on chronic postoperative pain and psychological factors 
such as pain catastrophizing, anxiety, or depression. The 
current study did not support the use of gabapentin for 
patients scheduled for TKA for the prevention of chronic 
postoperative pain.
4.2   Independent preoperative factors 
 predicting chronic postoperative pain
Preoperative pain intensity has been associated with 
chronic postoperative pain after, e.g. amputation [41, 
42], breast cancer surgery [43], and total joint replace-
ment [4]. Recent studies indicate that other preoperative 
factors could contribute to the preoperative pain intensity 
and that these factors are more predictive for the chronic 
postoperative pain than the pain intensity itself [8, 11]. 
Contrary to this, Wylde et al. [44] found that both preop-
erative pain at rest and while moving were not associated 
with pain 12-months after TKA surgery. Similarly, too pre-
viously, the current study found that preoperative pain 
while walking and at rest was associated with chronic 
postoperative pain but this study added that none of these 
was independent predictive factors.
Several studies have found that postoperative pain 
catastrophizing scores are lower following e.g. spine 
surgery for lumbar spinal stenosis, abdominal surgery, 
and TKA surgery [45, 46]. In addition, preoperative psy-
chological factors have been found to be associated with 
postoperative pain following various surgical procedures 
[4, 46–48]. In the context of TKA, Lewis et  al. [49] in a 
meta-analysis of 32 studies and found significant effects 
for catastrophizing, preoperative pain, mental health, and 
comorbidities for pain of at least 3 months after surgery. In 
contrast, Wylde et al. [50] found preoperative HADS-A to 
influence postoperative pain at 1 year, but not at 5 year fol-
low-up after TKA surgery, and preoperative PCS, HADS-D 
and pain self-efficacy were not found to be associated 
with pain at 1 year or at 5 year follow-up. Similarly, the 
current study found no association between preoperative 
PCS and postoperative pain scores. The current study did 
find HADS-D to be independently associated with postop-
erative pain while walking and at rest and preoperative 
HADS-A to be independently associated with postopera-
tive pain at rest, but notably all of the associates were 
weak.
Osteoarthritic pain develops over many years [51], and 
pain duration is associated with increased pain intensity 
and pain sensitivity [52]. The mean maximum plasma 
concentration of gabapentin is reached 3  h after oral 
administration, and the half-life time is 5–9 h indicating 
that three daily administrations are needed to maintain 
an optimal plasma level [53]. Future studies could focus 
on long-term preoperative treatment to identify whether 
long-term gabapentin influences pain and pain sensitiv-
ity and whether this is associated with lowered risk of 
chronic postoperative pain.
5   Conclusion
The current study showed that pre- and perioperative 
administrated gabapentin does not influence the develop-
ment of chronic postoperative pain or the revision rate at 
3–4 year follow-up after TKA. Thus, it does not support 
that short-term pre- and perioperative use of gabapentin 
can reduce the development of chronic postoperative pain 
after TKA.
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